Effects of additional context information in prescription drug information sheets on comprehension and risk and efficacy perceptions

Author:

Kelly BridgetORCID,O’Donoghue Amie,Parvanta Sarah,Boudewyns Vanessa,Oguntimein Oluwamurewa,Bann Carla,West Sue,Tzeng Janice,Chandler Caroline,Madson Gabriel,McCormack Lauren

Abstract

AbstractObjectiveTo determine how additional explanatory text (context) about drug side effects in a patient medication information handout affected comprehension and perceptions of risk and efficacy.MethodsWe conducted an online experiment with a national sample of 1,119 U.S. adults with rheumatoid arthritis and related conditions, sampled through random-digit dialing, address-based sampling, and online ads. We randomized participants to receive one of several versions of a patient information handout for a fictitious drug, either with or without additional context, then measured comprehension and other outcomes.ResultsAdditional qualitative context about warnings and side effects resulted in lower comprehension of side effect information, but not information about uses of the drug or warnings. The effect of additional context on risk perceptions depended on whether the medication handout was delivered online or through the mail. Those who received a hardcopy of the handout with additional context had higher perceived risk of side effects than those who saw the version without additional context.ConclusionMore clarifying information is not always better and may lead to cognitive overload, inhibiting comprehension.Practice implicationsAdditional research should further explore effects of context in online vs. hard-copy formats before practice implications can be determined.

Funder

U.S. Food and Drug Administration

Publisher

Springer Science and Business Media LLC

Subject

Pharmacy,Health Policy

Reference42 articles.

1. McCarthy M. FDA acts to limit exposure to acetaminophen in combination products. BMJ. 2014;348:g356.

2. Carpenter DM, Elstad EA, Blalock SJ, DeVellis RF. Conflicting medication information: prevalence, sources, and relationship to medication adherence. J Health Commun. 2014;19(1):67–81.

3. Narhi U. Sources of medicine information and their reliability evaluated by medicine users. Pharm World Sci. 2007;29(6):688–94.

4. Medication Guides for Prescription Drug Products, 21 C.F.R. Part 208 (1998). http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?CFRPart=208.

5. Patient Package Inserts for Estrogens, 21 C.F.R. Part 310.515 (2017). https://www.ecfr.gov/cgi-bin/text-idx?SID=46a777e6306938531b0a80829e912315&mc=true&node=se21.5.310_1515&rgn=div8

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3